(Q46419894)

English

European LeukemiaNet criteria for failure or suboptimal response reliably identify patients with CML in early chronic phase treated with imatinib whose eventual outcome is poor.

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

22 December 2017

http://europepmc.org/abstract/MED/18716134

European LeukemiaNet criteria for failure or suboptimal response reliably identify patients with CML in early chronic phase treated with imatinib whose eventual outcome is poor (English)

1 reference

Europe PubMed Central

PMC publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6143157&resulttype=core&format=json

12 May 2020

0 references

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

Francesco Dazzi

10

1 reference

Europe PubMed Central

PMC publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6143157&resulttype=core&format=json

12 May 2020

author name string

David Marin

1

1 reference

Europe PubMed Central

PMC publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6143157&resulttype=core&format=json

12 May 2020

Dragana Milojkovic

2

1 reference

Europe PubMed Central

PMC publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6143157&resulttype=core&format=json

12 May 2020

Eduardo Olavarria

3

1 reference

Europe PubMed Central

PMC publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6143157&resulttype=core&format=json

12 May 2020

Jamshid S Khorashad

4

1 reference

Europe PubMed Central

PMC publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6143157&resulttype=core&format=json

12 May 2020

Hugues de Lavallade

5

1 reference

Europe PubMed Central

PMC publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6143157&resulttype=core&format=json

12 May 2020

Alistair G Reid

6

1 reference

Europe PubMed Central

PMC publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6143157&resulttype=core&format=json

12 May 2020

Letizia Foroni

7

1 reference

Europe PubMed Central

PMC publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6143157&resulttype=core&format=json

12 May 2020

Katayoun Rezvani

8

1 reference

Europe PubMed Central

PMC publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6143157&resulttype=core&format=json

12 May 2020

Marco Bua

9

1 reference

Europe PubMed Central

PMC publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6143157&resulttype=core&format=json

12 May 2020

Jiri Pavlu

11

1 reference

Europe PubMed Central

PMC publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6143157&resulttype=core&format=json

12 May 2020

Matthias Klammer

12

1 reference

Europe PubMed Central

PMC publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6143157&resulttype=core&format=json

12 May 2020

Jaspal S Kaeda

13

1 reference

Europe PubMed Central

PMC publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6143157&resulttype=core&format=json

12 May 2020

John M Goldman

14

1 reference

Europe PubMed Central

PMC publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6143157&resulttype=core&format=json

12 May 2020

Jane F Apperley

15

1 reference

Europe PubMed Central

PMC publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6143157&resulttype=core&format=json

12 May 2020

language of work or name

0 references

publication date

20 August 2008

1 reference

Europe PubMed Central

PubMed publication ID

22 December 2017

http://europepmc.org/abstract/MED/18716134

1 reference

Europe PubMed Central

PMC publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6143157&resulttype=core&format=json

12 May 2020

112

1 reference

Europe PubMed Central

PMC publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6143157&resulttype=core&format=json

12 May 2020

12

1 reference

Europe PubMed Central

PMC publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6143157&resulttype=core&format=json

12 May 2020

4437-4444

1 reference

Europe PubMed Central

PMC publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6143157&resulttype=core&format=json

12 May 2020

Monitoring CML patients responding to treatment with tyrosine kinase inhibitors: review and recommendations for harmonizing current methodology for detecting BCR-ABL transcripts and kinase domain mutations and for expressing results

1 reference

https://pubmed.ncbi.nlm.nih.gov/18716134

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Dasatinib in imatinib-resistant Philadelphia chromosome-positive leukemias

1 reference

https://pubmed.ncbi.nlm.nih.gov/18716134

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Alpha-interferon in the treatment of chronic myeloid leukemia. The Italian Cooperative Study Group on Chronic Myeloid Leukemia.

1 reference

https://pubmed.ncbi.nlm.nih.gov/18716134

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Frequency of major molecular responses to imatinib or interferon alfa plus cytarabine in newly diagnosed chronic myeloid leukemia

1 reference

https://pubmed.ncbi.nlm.nih.gov/18716134

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Failure to achieve a major cytogenetic response by 12 months defines inadequate response in patients receiving nilotinib or dasatinib as second or subsequent line therapy for chronic myeloid leukemia

1 reference

https://pubmed.ncbi.nlm.nih.gov/18716134

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Cytogenetic and molecular monitoring of residual disease in chronic myeloid leukaemia

1 reference

https://pubmed.ncbi.nlm.nih.gov/18716134

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Cytogenetic and molecular responses and outcome in chronic myelogenous leukemia: need for new response definitions?

1 reference

https://pubmed.ncbi.nlm.nih.gov/18716134

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Nilotinib (formerly AMN107), a highly selective BCR-ABL tyrosine kinase inhibitor, is active in patients with imatinib-resistant or -intolerant accelerated-phase chronic myelogenous leukemia

1 reference

https://pubmed.ncbi.nlm.nih.gov/18716134

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Monitoring patients in complete cytogenetic remission after treatment of CML in chronic phase with imatinib: patterns of residual leukaemia and prognostic factors for cytogenetic relapse

1 reference

https://pubmed.ncbi.nlm.nih.gov/18716134

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Dasatinib induces notable hematologic and cytogenetic responses in chronic-phase chronic myeloid leukemia after failure of imatinib therapy

1 reference

https://pubmed.ncbi.nlm.nih.gov/18716134

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Characteristics of accelerated disease in chronic myelogenous leukemia

1 reference

https://pubmed.ncbi.nlm.nih.gov/18716134

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Finding of kinase domain mutations in patients with chronic phase chronic myeloid leukemia responding to imatinib may identify those at high risk of disease progression

1 reference

https://pubmed.ncbi.nlm.nih.gov/18716134

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Serial measurement of BCR-ABL transcripts in the peripheral blood after allogeneic stem cell transplantation for chronic myeloid leukemia: an attempt to define patients who may not require further therapy

1 reference

https://pubmed.ncbi.nlm.nih.gov/18716134

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Nilotinib in imatinib-resistant CML and Philadelphia chromosome-positive ALL

1 reference

https://pubmed.ncbi.nlm.nih.gov/18716134

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Evolving concepts in the management of chronic myeloid leukemia: recommendations from an expert panel on behalf of the European LeukemiaNet

1 reference

https://pubmed.ncbi.nlm.nih.gov/18716134

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Imatinib mesylate discontinuation in patients with chronic myelogenous leukemia in complete molecular remission for more than 2 years.

1 reference

https://pubmed.ncbi.nlm.nih.gov/18716134

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Five-year follow-up of patients receiving imatinib for chronic myeloid leukemia

1 reference

https://pubmed.ncbi.nlm.nih.gov/18716134

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Imatinib for newly diagnosed patients with chronic myeloid leukemia: incidence of sustained responses in an intention-to-treat analysis

1 reference

https://pubmed.ncbi.nlm.nih.gov/18716134

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Prognostic significance of additional cytogenetic abnormalities at diagnosis of Philadelphia chromosome-positive chronic granulocytic leukemia.

1 reference

https://pubmed.ncbi.nlm.nih.gov/18716134

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Chronic myeloid leukemia in chronic phase responding to imatinib: the occurrence of additional cytogenetic abnormalities predicts disease progression

1 reference

https://pubmed.ncbi.nlm.nih.gov/18716134

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1182/BLOOD-2008-06-162388

1 reference

Europe PubMed Central

PMC publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6143157&resulttype=core&format=json

12 May 2020

PMC publication ID

1 reference

Europe PubMed Central

PMC publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6143157&resulttype=core&format=json

12 May 2020

PubMed publication ID

1 reference

Europe PubMed Central

PMC publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6143157&resulttype=core&format=json

12 May 2020

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q46419894&oldid=1584546541"